POULVAC TRT VACCINE, LYOPHILISATE FOR SUSPENSION FOR SPRAY, EYE DROP OR NOSE DROP ADMINISTRATION FOR TURKEYS
POULVAC TRT VACCINE, LYOPHILISATE FOR SUSPENSION FOR SPRAY, EYE DROP OR NOSE DROP ADMINISTRATION FOR TURKEYS
Authorised
- Turkey rhinotracheitis virus, strain Clone K, Live
Product identification
Medicine name:
POULVAC TRT VACCINE, LYOPHILISATE FOR SUSPENSION FOR SPRAY, EYE DROP OR NOSE DROP ADMINISTRATION FOR TURKEYS
Poulvac TRT
Active substance:
- Turkey rhinotracheitis virus, strain Clone K, Live
Target species:
-
Turkey
Route of administration:
-
Ocular use
-
Intranasal use
-
Oculonasal use
Product details
Active substance and strength:
-
Turkey rhinotracheitis virus, strain Clone K, Live1584.89cell culture infective dose 501.00Dose
Pharmaceutical form:
-
Lyophilisate for suspension
Withdrawal period by route of administration:
-
Ocular use
- Turkey
-
All relevant tissues0day
-
-
Intranasal use
- Turkey
-
All relevant tissues0day
-
-
Oculonasal use
- Turkey
-
All relevant tissues0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01CD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- Cardboard boxes containing 1 vial of 1,000 doses
- Cardboard boxes containing 1 vial of 2,000 doses
- Cardboard boxes containing 1 vial of 5,000 doses
- Cardboard boxes containing 10 vials of 1,000 doses
- Cardboard boxes containing 10 vials of 2,000 doses
- Cardboard boxes containing 10 vials of 5,000 doses
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- PEI.V.01721.01.1
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0412/001
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
Germany
-
Greece
-
Italy
-
Netherlands
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 23/06/2023
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 23/06/2023
How useful was this page?: